The Effect of the Vein Imaging Device Used in Peripheral Intravenous Catheter Application on the Success of the Procedure in Patients Coming to the Pediatric Emergency Department
Launched by CELAL BAYAR UNIVERSITY · Jan 29, 2024
Trial Information
Current as of April 02, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special device that shows images of veins can help healthcare professionals successfully insert a peripheral intravenous catheter (PIC) in children who come to the pediatric emergency department. A PIC is a small tube placed in a vein to give medications when children are sick, especially if they have problems like dehydration or infections. Since children have smaller veins and may not be able to communicate well, finding the right vein can be challenging. The trial aims to see if using this vein imaging device makes the procedure quicker and easier for both the child and the nurse.
To participate in this study, children must be between the ages of 6 and 12 and currently receiving treatment that requires a PIC. Both the child and their parent or guardian need to agree to join the trial. If the child qualifies, they can expect the same nurse to place the PIC using a specific type of catheter. Researchers hope that by using the vein imaging device, they can reduce any discomfort and stress for the child during the procedure. The trial is currently recruiting participants, and every child's experience will help understand how to improve care in pediatric emergency situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The child is between the ages of 6-12,
- • The child is receiving treatment through peripheral vascular access,
- • Parent and child agree to participate in the research,
- • PIK placement is done by the same nurse,
- • PIK placement should be performed with the same catheter number (24-G or 22-G) and brand.
- Exclusion Criteria:
- • Children falling outside the inclusion criteria will be included in the exclusion criteria.
Trial Officials
Duygu Karaarslan
Study Director
Manisa Celal Bayar University
About Celal Bayar University
Celal Bayar University is a prominent academic institution dedicated to advancing medical research and clinical practice. With a strong emphasis on innovation and collaboration, the university sponsors clinical trials aimed at exploring new therapeutic approaches and improving patient outcomes. Leveraging its state-of-the-art facilities and a team of experienced researchers, Celal Bayar University fosters an environment that promotes scientific inquiry and ethical standards in clinical research, contributing significantly to the body of medical knowledge and the development of effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manisa, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported